Location History:
- 702 30 Orebro, SE (1983)
- 30 Orebro, SE (1988)
- 63 Orebro, SE (1989)
- Huddinge, SE (1991 - 2009)
Company Filing History:
3 out of 184 
2 out of 76 
2 out of 7 Years Active: 1983-2009
Title: Rolf A Johansson: Innovator in Pharmaceutical Compounds
Introduction
Rolf A Johansson, a prominent inventor based in Huddinge, Sweden, has made significant contributions to the field of pharmaceuticals. With a portfolio of 11 patents, he has focused his efforts on developing novel compounds with potential therapeutic applications.
Latest Patents
Among his latest contributions is the invention of 3,3-diphenylpropylamines, which encompasses the preparation and application of these pharmaceutical compounds. These compounds are distinguished by a specific chemical formula where R signifies hydrogen or methyl, and R and R independently represent various groups such as hydrogen, methyl, methoxy, hydroxy, carbamoyl, sulphamoyl, or halogen. The innovation also includes tertiary amino groups and methods for their preparation. Rolf's work highlights the significance of these compounds in the creation of pharmaceutical compositions and their use in drug preparation, including the possibility of optical isomers.
Career Highlights
Rolf has garnered experience in notable organizations, with his tenure at Pharmacia AB being one of his key career highlights. His work has not only advanced drug discovery but has also pushed the boundaries of medicinal chemistry through his numerous patents.
Collaborations
Throughout his career, Rolf A Johansson has collaborated with several notable professionals, including Lisbeth Nilvebrant and Martin Haraldsson. These partnerships have enriched his research endeavors and contributed to the innovation of pharmaceutical solutions.
Conclusion
Rolf A Johansson's innovative spirit and dedication to his work have led to significant advancements in the pharmaceutical industry. His contributions through his patents serve as a testament to his expertise and commitment to improving healthcare solutions. As the landscape of medicine evolves, inventors like Rolf play a crucial role in developing the next generation of therapeutic agents.